TARDBP and amyotrophic lateral sclerosis: In ALS, TDP-43 aggregation is seen in ~ 97% of cases, and recent evidence demonstrates that dysregulation of TDP-43 can drive changes in intermediate filament expression [83, 85], translation [84], localization [39] and stoichiometry, resulting in cytoskeletal disorganization [84].